目的考察盐酸普罗帕酮注射液的稳定性。
Objective To study the stability of injection of propafenone hydrochloride.
目的：研究普罗帕酮对心室肌细胞的影响作用。
Objective: To study the electrophysiology effect of Propafenone on ventricle muscle cell of rats.
普罗帕酮对心室复极时间无影响，可延长心室除极时间。
Propafenone has no effects on QT interval, however it prolongs ventricular depolarization.
其他药物，如氟卡尼和普罗帕酮可以帮助维护正常的节奏。
Other drugs such as flecainide and propafenone can help maintain a normal rhythm.
目的研究普罗帕酮心肌变力性作用并从组织水平探讨其作用机制。
Aim To investigate the effects of propafenone on myocardium inotropism and explore it's possible mechanism in isolated papillary muscle of guinea pig.
结论倍他乐克与盐酸地尔硫联合治疗阵发性房颤疗效优于普罗帕酮。
Conclusion Betaloc in combination with diltiazem is superior to propafenone in treating paf.
目的：观察倍他乐克联合普罗帕酮治疗女性更年期心律失常的疗效。
Objective: To observe the combined propafenone for treatment of female menopause metoprolol arrhythmia.
结论：倍他乐克联合普罗帕酮治疗女性更年期心律失常患者的疗效确切。
Conclusion: metoprolol arrhythmia combined propafenone for treatment of female menopausal patients with curative effect.
目的：研究普罗帕酮(PPF)经人肝cyp3a 4代谢的立体选择性。
AIM: To investigate the stereoselective metabolism of propafenone (PPF) by human liver CYP3A4.
目的：观察和比较静脉注射胺碘酮、普罗帕酮治疗宽qrs波群心动过速的即时疗效和安全性。
Objective: To compare the efficacy and safety of intravenous amiodarone and propafenone for broad QRS tachycardia.
以盐酸普罗帕酮为模型药物，比较了海藻酸钠、脱乙酰壳多糖以及两者混合物骨架的缓释作用及释药特性。
We studied sustained release characteristics of sodium alginate (NaAlg), chitosan (cs) and their mixture, incorporation with propafenone hydrochloride (PF) as a model drug.
治疗组36例，采用倍他乐克联合普罗帕酮片治疗，对照组28例，单独采用普罗帕酮片治疗，两组均治疗4周。
The treatment group 36 cases, using propafenone tablets metoprolol combined treatment, the control group 28 cases, a separate sheet with propafenone treatment, both groups were treated for 4 weeks.
方法：采用回顾性研究方法，对1994—2007年国内医药期刊报道的366例普罗帕酮致不良反应病例进行统计、分析。
METHODS A retrospective study was carried out, with collection, statistic and analyses 366 cases of adverse drug reactions induced by propafenone reported in domestic journals during 1994—2007.
目的比较静脉应用普罗帕酮与毛花苷丙治疗快速心房颤动（简称房颤）并发充血性心力衰竭（心衰）患者心室率的即时效应及安全性。
Objective To evaluate the efficacy and safety of intravenous fenopraine and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart failure.
目的比较静脉应用普罗帕酮与毛花苷丙治疗快速心房颤动（简称房颤）并发充血性心力衰竭（心衰）患者心室率的即时效应及安全性。
Objective To evaluate the efficacy and safety of intravenous fenopraine and lanatoside C for the treatment of rapid ventricular rate in patients with atrial fibrillation and congestive heart failure.
应用推荐